The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
{2-[2-(4-{[5-(dimethylcarbamoyl)pyridin-2-yl]oxy}piperidin-1-yl)-2-oxoethyl]phenyl}boronic acid ID: ALA4093246
PubChem CID: 137654706
Max Phase: Preclinical
Molecular Formula: C21H26BN3O5
Molecular Weight: 411.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)C(=O)c1ccc(OC2CCN(C(=O)Cc3ccccc3B(O)O)CC2)nc1
Standard InChI: InChI=1S/C21H26BN3O5/c1-24(2)21(27)16-7-8-19(23-14-16)30-17-9-11-25(12-10-17)20(26)13-15-5-3-4-6-18(15)22(28)29/h3-8,14,17,28-29H,9-13H2,1-2H3
Standard InChI Key: SFPKXCDZSAEQNQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 32 0 0 0 0 0 0 0 0999 V2000
21.9513 -20.6361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9502 -21.4556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6582 -21.8646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3679 -21.4552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3650 -20.6325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6564 -20.2272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6580 -22.6818 0.0000 B 0 0 0 0 0 0 0 0 0 0 0 0
21.9502 -23.0902 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.3656 -23.0906 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.2421 -21.8637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5347 -21.4545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8267 -21.8626 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5354 -20.6373 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.1221 -21.4481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4162 -21.8527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4113 -22.6702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1185 -23.0815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8306 -22.6753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7017 -23.0756 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.9959 -22.6637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0024 -21.8466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2974 -21.4349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5868 -21.8403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5857 -22.6617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2913 -23.0698 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8805 -21.4294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8831 -20.6122 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1714 -21.8357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4650 -21.4248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1688 -22.6529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
7 8 1 0
7 9 1 0
2 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
12 18 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
16 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
26 27 2 0
26 28 1 0
28 29 1 0
28 30 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 411.27Molecular Weight (Monoisotopic): 411.1966AlogP: ┄#Rotatable Bonds: ┄Polar Surface Area: ┄Molecular Species: ┄HBA: ┄HBD: ┄#RO5 Violations: ┄HBA (Lipinski): ┄HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: ┄CX LogD: ┄Aromatic Rings: ┄Heavy Atoms: ┄QED Weighted: ┄Np Likeness Score: ┄
References 1. Ogiyama T, Yamaguchi M, Kurikawa N, Honzumi S, Terayama K, Nagaoka N, Yamamoto Y, Kimura T, Sugiyama D, Inoue SI.. (2017) Design, synthesis, and pharmacological evaluation of a novel series of hormone sensitive lipase inhibitor., 25 (17): [PMID:28756012 ] [10.1016/j.bmc.2017.07.028 ]